XNAS
BioNexus Gene Lab Corp is a Wyoming corporation with two principal operating subsidiaries in Malaysia: Chemrex Corporation Sdn. Bhd. (Chemrex) and MRNA Scientific Sdn. Bhd. (MRNA Scientific). Chemrex is engaged in the distribution of chemical raw materials, mainly for industrial applications in Southeast Asia. MRNA Scientific is engaged in the development and provision of blood-based genomic screening services intended to support early disease risk assessment and health management. Trading of industrial chemicals- Includes trading of industrial chemicals. Provision for genomic screening services- includes in commercializing proprietary blood-based diagnostic test for early disease detection. Investment holding- Investment holding, are its segments.
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-05-15 | Q1 2026 | — | -0.23 | — | $22,842 | — | +0.00% | -0.20% | — |
| 2026-04-14 | Q4 2025 | — | -0.52 | — | $483,760 | — | +0.00% | +4.15% | -8.76% |
| 2025-11-14 |
| Q3 2025 |
| — |
| -0.40 |
| — |
| $2.5M |
| — |
| — |
| — |
| — |
| 2025-08-18 | Q2 2025 | — | -0.34 | — | $2.3M | — | -3.76% | +6.01% | +7.14% |
| 2025-04-15 | Q4 2024 | — | -0.07 | — | $2.5M | — | +0.75% | +5.28% | +14.72% |
| 2024-11-15 | Q3 2024 | — | -0.02 | — | $2.6M | — | -2.17% | -2.93% | -13.70% |
| 2024-08-14 | Q2 2024 | — | 0.01 | — | $2.0M | — | -5.00% | -1.81% | -9.44% |
| 2024-05-15 | Q1 2024 | — | -0.02 | — | $2.4M | — | -1.72% | -5.79% | -23.79% |
Showing last 8 quarters.